Indeed, it was shown that HOXB5 expression was positively correlated with the sensitivity of AML cells to bortezomib, an NF-κB pathway inhibitor in our data (Shahshahan et al., 2011). The gene discussed is HOXB5; the disease is acute myeloid leukemia.